You are here

Polivy

ASH: Roche offers glimpse of Columvi-Polivy combo's early lymphoma data as phase 3 kicks off

Fierce Pharma

Mon, 12/11/23 - 10:50 pm

diffuse large B-cell lymphoma

Roche, mirroring Novartis, guilty of most serious marketing breach for Polivy website

Fierce Pharma

Mon, 07/17/23 - 08:44 am

pharma marketing

FDA Green Lights Roche's Polivy in First-Line DLBCL

BioSpace

Thu, 04/20/23 - 10:45 am

diffuse large B-cell lymphoma

FDA adcomm votes 11-2 to expand Roche's Polivy label in DLBCL

Endpoints

Thu, 03/9/23 - 10:21 pm

FDA advisers question efficacy of Roche’s Polivy in first line LBCL

BioSpace

Wed, 03/8/23 - 11:30 am

large B-cell lymphoma

Roche’s Polivy continues its regulatory dance, will head to FDA for a form of blood cancer

Endpoints

Tue, 08/16/22 - 11:17 am

diffuse large B-cell lymphoma

ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts survival in early-stage lymphoma

Endpoints

Tue, 12/14/21 - 11:12 am

antibody-drug conjugate

Roche sets bar in early lymphoma treatment with Polivy study results

BioPharma Dive

Tue, 08/10/21 - 11:23 pm

On a quest to treat newly diagnosed lymphoma patients, Roche teases positive pivotal data

Endpoints

Mon, 08/9/21 - 11:07 am

diffuse large B-cell lymphoma

U.K. Regulatory Advisor Rejects Roche Cancer Drug

Motley Fool

Wed, 02/26/20 - 11:23 pm

Five drugs, including two Novartis therapies, win EMA endorsement

Endpoints

Fri, 11/15/19 - 12:22 pm

Roche snags first-in-class FDA nod for lymphoma drug Polivy

Fierce Pharma

Mon, 06/10/19 - 06:07 pm

diffuse large B-cell lymphoma